Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

Trends and Updated Statistics of Lung Cancer in Korea

  • Park, Chan Kwon (Division of Pulmonology, Department of Internal Medicine, The Catholic University of Korea) ;
  • Kim, Seung Joon (Division of Pulmonology, Department of Internal Medicine, The Catholic University of Korea)
  • Received : 2019.02.23
  • Accepted : 2019.03.08
  • Published : 2019.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Lee C, Kang KH, Koh Y, Chang J, Chung HS, Park SK, et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer 2000;30:15-22. https://doi.org/10.1016/S0169-5002(00)00126-4
  2. In KH, Kwon YS, Oh IJ, Kim KS, Jung MH, Lee KH, et al. Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a Korean Lung Cancer Registry Study. Lung Cancer 2009;64:232-7. https://doi.org/10.1016/j.lungcan.2008.08.005
  3. Kim YC, Won YJ. The development of the Korean Lung Cancer Registry (KALC-R). Tuberc Respir Dis 2019;82:91-3. https://doi.org/10.4046/trd.2018.0032
  4. Shin A, Oh CM, Kim BW, Woo H, Won YJ, Lee JS. Lung cancer epidemiology in Korea. Cancer Res Treat 2017;49:616-26. https://doi.org/10.4143/crt.2016.178
  5. Kim HC, Jung CY, Cho DG, Jeon JH, Lee JE, Ahn JS, et al. Clinical characteristics and prognostic factors of lung cancer in Korea: a pilot study of data from the Korean nationwide lung cancer registry. Tuberc Respir Dis 2019;82:118-25. https://doi.org/10.4046/trd.2017.0128
  6. Park JY, Jang SH. Epidemiology of lung cancer in Korea: recent trends. Tuberc Respir Dis 2016;79:58-69. https://doi.org/10.4046/trd.2016.79.2.58
  7. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat 2018;50:303-16. https://doi.org/10.4143/crt.2018.143
  8. Henley SJ, Gallaway S, Singh SD, O'Neil ME, Buchanan Lunsford N, Momin B, et al. Lung cancer among women in the United States. J Womens Health (Larchmt) 2018;27:1307-16. https://doi.org/10.1089/jwh.2018.7397
  9. Bonner MR, Bennett WP, Xiong W, Lan Q, Brownson RC, Harris CC, et al. Radon, secondhand smoke, glutathione-Stransferase M1 and lung cancer among women. Int J Cancer 2006;119:1462-7. https://doi.org/10.1002/ijc.22002
  10. Ahn YS, Kang SK. Asbestos-related occupational cancers compensated under the Industrial Accident Compensation Insurance in Korea. Ind Health 2009;47:113-22. https://doi.org/10.2486/indhealth.47.113
  11. Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: role of estrogens. Expert Rev Respir Med 2010;4:509-18. https://doi.org/10.1586/ers.10.50
  12. Silveyra P, Floros J. Air pollution and epigenetics: effects on SP-A and innate host defence in the lung. Swiss Med Wkly 2012;142:w13579.
  13. Kim CH, Lee YC, Hung RJ, McNallan SR, Cote ML, Lim WY, et al. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Int J Cancer 2014;135:1918-30. https://doi.org/10.1002/ijc.28835
  14. Paris C, Do P, Mastroianni B, Dixmier A, Dumont P, Pichon E, et al. Association between lung cancer somatic mutations and occupational exposure in never-smokers. Eur Respir J 2017;50:1700716. https://doi.org/10.1183/13993003.00716-2017
  15. Jia PL, Zhang C, Yu JJ, Xu C, Tang L, Sun X. The risk of lung cancer among cooking adults: a meta-analysis of 23 observational studies. J Cancer Res Clin Oncol 2018;144:229-40. https://doi.org/10.1007/s00432-017-2547-7
  16. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers: a different disease. Nat Rev Cancer 2007;7:778-90. https://doi.org/10.1038/nrc2190

Cited by

  1. High PD-L1 Expression is Associated with Unfavorable Clinical Outcome in EGFR -Mutated Lung Adenocarcinomas Treated with Targeted Therapy vol.13, 2019, https://doi.org/10.2147/ott.s271011
  2. Serum Reactive Oxygen Species Modulator 1 as a Novel Predictive Biomarker for Resected Lung Adenocarcinoma: A Retrospective Pilot Study vol.14, 2021, https://doi.org/10.2147/ott.s336399
  3. Biomarkers and diagnostic tools for lung cancer vol.64, pp.1, 2019, https://doi.org/10.5124/jkma.2021.64.1.66
  4. Treatment outcomes and safety of afatinib in advanced squamous cell lung cancer progressed after platinum‐based doublet chemotherapy and immunotherapy ( SPACE study) vol.12, pp.8, 2019, https://doi.org/10.1111/1759-7714.13880
  5. Recent Trends of Lung Cancer in Korea vol.84, pp.2, 2021, https://doi.org/10.4046/trd.2020.0134
  6. The relationship between TEM8 and early diagnosis and prognosis of lung cancer vol.112, pp.3, 2019, https://doi.org/10.23736/s0026-4806.20.06444-7